HEALTH HEADLINE Updated today

• one Professor Tan Xinggui, academic inheritance tutor of the Chinese Society of Traditional Chinese Medicine, inaugurated the inheritance workstation in Tongyitang Traditional Chinese Medicine Museum

  On September 22, 2024, the unveiling ceremony of Professor Tan Xinggui, the academic inheritance tutor of the Chinese Society of Traditional Chinese Medicine, was held in Tongyitang Museum of Traditional Chinese Medicine, Zhangpu County, Zhangzhou City, Fujian Province. Pang Yuzhou, vice president of Guangzhou University of Traditional Chinese Medicine, and vice president of Hubei University of Traditional Chinese Medicine were held

• two New trends of brain health market: the first choline glycinate product of Keyizhi was launched

  Brain health plays an increasingly significant role in the whole nutrition and health care market! As early as the "2023 China Brain Health Nutrition Health Care E-commerce Market Insight", there was data disclosure that the growth of the brain health market outperformed the market, among which the demand for brain health is the strongest

• three Menarini participated in the 17th Xipu Conference, pressing forward without fear of challenges

  From August 9 to August 14, the 17th Xipu Conference was held in Boao, Hainan, and Menarini China was invited to attend the conference. At the meeting, Chen Jialin, CEO of Menarini China, received an exclusive interview with Xinhuanet and expressed his views on topics such as the upgrading of the pharmaceutical and health industry and innovative cooperation. He

• four European LSI SILDERMA and Jianzhijia have reached an exclusive strategic cooperation in China

  On September 11, a product launch meeting on health+beauty was held in Kunming. The famous pharmaceutical company LSI SILDERMA from Europe and Jianzhijia Pharmaceutical Chain Group Co., Ltd. reached an exclusive strategic cooperation in China, and many of its high-quality products will be officially stationed in Jianzhijia

• five Novartis in-depth expansion of radioligand therapy: precise positioning and strike, opening a new chapter for prostate cancer treatment

  Prostate cancer is one of the most common malignant tumors in men. "The Lancet Major Report on Prostate Cancer" pointed out that the number of prostate cancer cases in the world is expected to increase from 1.4 million annually in 2020 to 2.9 million annually in 2040, and the number of patients will double

• one Professor Tan Xinggui, academic inheritance tutor of the Chinese Society of Traditional Chinese Medicine, inaugurated the inheritance workstation in Tongyitang Traditional Chinese Medicine Museum

• two New trends of brain health market: the first choline glycinate product of Keyizhi was launched

• three Menarini participated in the 17th Xipu Conference, pressing forward without fear of challenges

• four European LSI SILDERMA and Jianzhijia have reached an exclusive strategic cooperation in China

• five Decision of the Standing Committee of the National People's Congress on Implementing the Gradual Extension of the Statutory Retirement Age

• six Novartis in-depth expansion of radioligand therapy: precise positioning and strike, opening a new chapter for prostate cancer treatment

• seven [Mid Autumn Festival Health Ceremony] From September 14 to 18, the top three doctors of vitiligo in western China held a joint consultation, specializing in vitiligo and vitiligo!